SEC Form 4 · accession 0001209191-18-012408
GENOMIC HEALTH INC · GHDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Laura Leber
Officer — Chief Communication Officer
Period of report
Feb 20, 2018
Accepted (ET)
Feb 22, 2018 · 4:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001131324
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3,F4 | Feb 20, 2018 | S | 3,174 | $32.8936 | D | 16,731 | D | |
| Common StockF1,F5,F4 | Feb 20, 2018 | S | 200 | $33.38 | D | 16,531 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on May 11, 2017.
- F2Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- F3Represents weighted average sale price. Actual sale prices ranged from $32.35 to $33.32.
- F4Includes an aggregate of 11,787 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- F5Represents actual sale price.